Abcuro is a Biotech company based in Durham, North Carolina. It has raised $200M in total funding. Latest round: Series C.
Abcuro funding overview
Abcuro is a Biotech company based in Durham, North Carolina. Abcuro has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in February 2025. The round record for Abcuro runs through 2025; nothing later has been disclosed. Investors on record include NEA, Foresite Capital, RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital and 8 others. 14 distinct backers are named across the disclosed rounds.
Abcuro at a glance
Total raised
$200M
Latest round
Series C
Latest round date
February 2025
Industry
Biotech
Headquarters
Durham, North Carolina
Notable investors
NEA, Foresite Capital, RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital, Sanofi Ventures, Pontifax
Frequently asked about Abcuro funding
How much has Abcuro raised?
Abcuro has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Abcuro?
NEA, Foresite Capital, RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital are named among the investors backing Abcuro.
What was the latest Abcuro funding round?
The most recent disclosed round is a Series C, announced in February 2025.
Where is Abcuro based?
Abcuro is based in Durham, North Carolina.
What sector does Abcuro operate in?
Abcuro is tracked under Biotech from Durham, North Carolina, with $200M in disclosed funding.
When did Abcuro last raise?
The last disclosed Abcuro round closed in February 2025 at Series C.
We update the Abcuro record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Durham and their backers are listed below.
